Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Special Drug Use Surveillance of ADZYNMA Intravenous 1500 (All-Case Investigation)
jRCT2031240130Recruiting
- Sponsor
- Takeda
- Start
- May 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of conestat alfa in thrombotic thrombocytopenic purpura (TTP), sponsored by Takeda. Primary endpoint: Number of participants who experience at least one treatment-emergent adverse event (TEAE). Started May 2024; status: recruiting.
02
Drugs
conestat alfa
03
Conditions
thrombotic thrombocytopenic purpura (TTP)
Beyond the preview
Go deeper on jRCT2031240130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240130.